Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the production of DPP-4 inhibitors like vildagliptin and saxagliptin. Its chiral structure enables selective interaction with biological targets, enhancing drug efficacy. The compound's rigid bicyclic framework contributes to metabolic stability, making it valuable in developing orally active pharmaceuticals. It is also employed in the preparation of enzyme inhibitors and bioactive molecules targeting neurological disorders due to its ability to cross the blood-brain barrier.